On a per-share basis, the Durham, North Carolina-based company said it had a loss of 61 cents.
The biotechnology company posted revenue of $54,200 in the period. Its adjusted revenue was $54,000.
The company's shares closed at 13 cents. A year ago, they were trading at $3.75.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARGS at https://www.zacks.com/ap/ARGS
Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.